2022 year

Current location:Home>>Publications>>2022 year>>

Shile Qi, Jing Sui, Godfrey Pearlson, Juan Bustillo, Nora I. Perrone-Bizzozero, Peter Kochunov, Jessica A. Turner, Zening Fu, Wei Shao, Rongtao Jiang, Xiao Yang, Jingyu Liu, Yuhui Du, Jiayu Chen, Daoqiang Zhang & Vince D. Calhoun. Derivation and utility of schizophrenia polygenic risk associated multimodal MRI frontotemporal network. Nat Commun 13, 4929, 2022. (Impact factor:17.694)

时间:2022-11-03 19:12:32   来源:  点击:[238]


Schizophrenia is a highly heritable psychiatric disorder characterized by widespread functional and structural brain abnormalities. However, previous association studies between MRI and polygenic risk were mostly ROI-based single modality analyses, rather than identifying brain-based multimodal predictive biomarkers. Based on schizophrenia polygenic risk scores (PRS) from healthy white people within the UK Biobank dataset (N = 22,459), we discovered a robust PRS-associated brain pattern with smaller gray matter volume and decreased functional activation in frontotemporal cortex, which distinguished schizophrenia from controls with >83% accuracy, and predicted cognition and symptoms across 4 independent schizophrenia cohorts. Further multi-disease comparisons demonstrated that these identified frontotemporal alterations were most severe in schizophrenia and schizo-affective patients, milder in bipolar disorder, and indistinguishable from controls in autism, depression and attention-deficit hyperactivity disorder. These findings indicate the potential of the identified PRS-associated multimodal frontotemporal network to serve as a trans-diagnostic gene intermediated brain biomarker specific to schizophrenia.